Indications and uses
Uses: Supporting immune System Helps healthy colon and intestinal flora
Uses: Supporting immune System Helps healthy colon and intestinal flora
Directions: Use once a day; for better result, use 3 packs daily
ACTIVE INGREDIENT: Lactobacillus plantarum 6.736%
PURPOSE: Immune Support
Uses:
Supporting immune System
Helps healthy colon and intestinal flora
Directions:
Use once a day; for better result, use 3 packs daily
WARNINGS:
Do not use if allergic to any ingredients
When using this product, seek for health care professional if you are pregnant or nursing
Keep out of reach of the children
INACTIVE INGREDIENT:
Lactose powder, Glucose powder, Galactooligosaccharide, Fructooligosaccharide, Mandarin orange extract powder, Citron fruit juice powder, Orange flavor powder
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70130-001-02 | 2020-02-14 | C162847 | 48780-1 | 9d75b9d0-d240-f424-e053-dadaa90a57ce | Drug Facts |
| 70130-001-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d240-f424-e053-dadaa90a57ce | Drug Facts |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Lactobacillus Plantarum | ACTIVE INGREDIENT | QFC21096ON | 1 | |
| LACTOBACILLUS PLANTARUM | ACTIVE MOIETY | QFC21096ON | 1 | |
| CITRUS JUNOS FRUIT | INACTIVE INGREDIENT | 53KHW58C1V | 1 | |
| DEXTROSE, UNSPECIFIED FORM | INACTIVE INGREDIENT | IY9XDZ35W2 | 1 | |
| LACTOSE, UNSPECIFIED FORM | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| ORANGE | INACTIVE INGREDIENT | 5EVU04N5QU | 1 | |
| TANGERINE | INACTIVE INGREDIENT | KH3E3096OO | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70130-001 | 70130-001-01, 70130-001-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Lactobacillus Plantarum | QFC21096ON | ACTIB |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
| TANGERINE | KH3E3096OO | IACT |
| CITRUS JUNOS FRUIT | 53KHW58C1V | IACT |
| ORANGE | 5EVU04N5QU | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | SOLUTION / INTRAVENOUS | 5.05 %w/v | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAVENOUS | 5 %w/v | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRAVENOUS | 51.7 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | POWDER, FOR SOLUTION / ORAL | NA | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | SPRAY, METERED / NASAL | 50 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | SYRUP / ORAL | 620 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET / SUBLINGUAL | 115.78 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRATHECAL | 1925 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRASPINAL | 75 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | PASTILLE / ORAL | 826 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET, COATED / ORAL | 132 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | SOLUTION / ORAL | 2489 mg/5ml | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | CONCENTRATE / ORAL | 400 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | LOZENGE / BUCCAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE, UNSPECIFIED FORM | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| DEXTROSE, UNSPECIFIED FORM | DEXTROSE | IY9XDZ35W2 | POWDER / VAGINAL | 430 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8ad6b342-1858-42ac-968b-803d4bb5f993 | a4f76c61-aec7-4e80-88f2-330a8a4cda11 | 2021-05-18 | Warnings | a4f76c61-aec7-4e80-88f2-330a8a4cda11 |
Adverse event summaries are temporarily unavailable. Other product information remains available.